"Bard" Magg preferred to ditch the core tissue sampling needle - Taiwan Registration ccc07b18de4e9fcf672ef561780b8110

Access comprehensive regulatory information for "Bard" Magg preferred to ditch the core tissue sampling needle in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ccc07b18de4e9fcf672ef561780b8110 and manufactured by Bard Peripheral Vascular, Inc.;; CareFusion D.R. 203 Ltd.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.